Literature DB >> 10692993

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

T Oettinger1, M Jørgensen, A Ladefoged, K Hasløv, P Andersen.   

Abstract

The original Mycobacterium bovis Bacillus Calmette Guérin vaccine strain has developed into several different substrains which have been used for production of BCG vaccines throughout the world since 1921. Based on the latest genetic and antigenic knowledge, as well as the early literature reports on BCG vaccination, we are able to fit the different pieces of the BCG puzzle together and outline the origin of the different substrains of M. bovis BCG. The BCG vaccine substrains analysed demonstrate two distinct patterns, with an abrupt change consisting of a loss of several genes and altered biochemical characteristics in strains originating from Institut Pasteur after 1927. Further evidence from the literature is provided that a change occurred in virulence of the BCG parent strain at Institut Pasteur in the late 1920s. Based on this information a genealogical tree is proposed and discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10692993     DOI: 10.1054/tuld.1999.0206

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  57 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family.

Authors:  Limei Meng Okkels; Inger Brock; Frank Follmann; Else Marie Agger; Sandra M Arend; Tom H M Ottenhoff; Fredrik Oftung; Ida Rosenkrands; Peter Andersen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

3.  A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.

Authors:  Shen-An Hwang; Katarzyna Wilk; Marian L Kruzel; Jeffrey K Actor
Journal:  Vaccine       Date:  2009-04-05       Impact factor: 3.641

Review 4.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 5.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

6.  The BCG Strain Pool: Diversity Matters.

Authors:  Daria Bottai; Roland Brosch
Journal:  Mol Ther       Date:  2016-02       Impact factor: 11.454

7.  Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals.

Authors:  Malathesha Ganachari; Jorge A Ruiz-Morales; Juan C Gomez de la Torre Pretell; Jeffrey Dinh; Julio Granados; Pedro O Flores-Villanueva
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

8.  Strain-specific differences in the genetic control of two closely related mycobacteria.

Authors:  Tania Di Pietrantonio; Carmen Hernandez; Manon Girard; Annie Verville; Marianna Orlova; Adam Belley; Marcel A Behr; J Concepción Loredo-Osti; Erwin Schurr
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

9.  Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.

Authors:  Adam Belley; David Alexander; Tania Di Pietrantonio; Manon Girard; Joses Jones; Erwin Schurr; Jun Liu; David R Sherman; Marcel A Behr
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model.

Authors:  S M Irwin; A Goodyear; A Keyser; R Christensen; J M Troudt; J L Taylor; A Bohsali; V Briken; A A Izzo
Journal:  Clin Vaccine Immunol       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.